Hint mode is switched on Switch off

FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD) (US33738R8372)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US33738R8372
FTXH ISIN
Exchange Traded Funds (ETF)
Type of fund
First Trust
Provider
39.59 USD
NAV per Share | 07/08/2026
20/09/2016
Inception Date
4 times per year
Dividend payments
CEOXMX
CFI
FTXH
Ticker
Formed
Status
Equity
Investment category
Healthcare
Sector
USA
Investor locations
Nasdaq US Smart Pharmaceuticals Index
Benchmark
0.6 %
Total Cost Ratio
37.89 mln USD
Fund NAV | 15/07/2026
No
UCITS
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Yield on 07/08/2026, NASDAQ

  • YTD
    1.9 %
  • 1M
    -3.36 %
  • 3M
    -4.14 %
  • 6M
    6.24 %
  • 1Y
    35.3 %
  • 3Y
    33.95 %
  • 5Y
    36.59 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (FTXH)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

FTXH profile

The First Trust Nasdaq Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 20.09.2016 with unique ISIN - US33738R8372. Main exchange is NASDAQ and ticker symbol is FTXH. The total expense ratio is 0.6%. The First Trust Nasdaq Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Structure FTXH on 07/08/2026

Download structure in Excel
Paper Value
Eli Lilly and Company 7.43%
AbbVie Inc. 7.01%
Johnson & Johnson 6.9%
Merck & Co., Inc. 6.87%
Bristol-Myers Squibb Company 6.86%
Viatris Inc. 3.64%
Biogen Inc. 3.58%
Amgen Inc. 3.51%
Cardinal Health, Inc. 3.42%
Regeneron Pharmaceuticals, Inc. 3.33%
Vertex Pharmaceuticals Incorporated 3.31%
Pfizer Inc. 3.2%
Gilead Sciences, Inc. 2.95%
United Therapeutics Corporation 2.64%
Jazz Pharmaceuticals Plc 2.57%
Incyte Corporation 2.47%
Illumina, Inc. 2.06%
Zoetis Inc. 1.83%
Charles River Laboratories International, Inc. 1.7%
Exelixis, Inc. 1.66%
Halozyme Therapeutics, Inc. 1.55%
Medpace Holdings, Inc. 1.52%
Neurocrine Biosciences, Inc. 1.29%
Alkermes Plc 1.23%
BioMarin Pharmaceutical Inc. 1.21%
PTC Therapeutics, Inc. 1.2%
Twist Bioscience Corporation 1.12%
Spyre Therapeutics, Inc. 1.11%
10X Genomics, Inc. (Class A) 1.03%
Travere Therapeutics, Inc. 0.94%
Guardant Health, Inc. 0.82%
TG Therapeutics, Inc. 0.75%
Elanco Animal Health Incorporated 0.72%
Protagonist Therapeutics, Inc. 0.72%
Amneal Pharmaceuticals, Inc. 0.7%
Arrowhead Pharmaceuticals, Inc. 0.69%
Ligand Pharmaceuticals Inc. (Class B) 0.67%
Arcus Biosciences, Inc. 0.64%
Roivant Sciences Ltd. 0.57%
ACADIA Pharmaceuticals Inc. 0.54%
Krystal Biotech, Inc. 0.54%
Kymera Therapeutics, Inc. 0.54%
Mirum Pharmaceuticals, Inc. 0.5%
Moderna, Inc. 0.5%
Arcutis Biotherapeutics, Inc. 0.43%
Supernus Pharmaceuticals, Inc. 0.39%
Tarsus Pharmaceuticals, Inc. 0.39%
Ionis Pharmaceuticals, Inc. 0.32%
Alnylam Pharmaceuticals, Inc. 0.3%
US Dollar 0.15%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.